5522 DAN
Pill imprint 5522 DAN has been identified as Hydroxyzine hydrochloride 10 mg.
Hydroxyzine is used in the treatment of pain; anxiety; nausea/vomiting; sedation; allergies (and more), and belongs to the drug classes antihistamines, miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy.
Hydroxyzine 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydroxyzine hydrochloride Images
- Imprint:
-
5522
DAN - Strength:
- 10 mg
- Color:
- Orange
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
croscarmellose sodium
FD&C Yellow No. 6
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
titanium dioxide
- Drug Class:
- Antihistamines
Miscellaneous anxiolytics, sedatives and hypnotics - Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-5522
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66267-0112 | Nucare Pharmaceuticals Inc (repackager) |
| 68115-0174 | Dispensexpress Inc (repackager) |
| 66336-0795 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More HydrOXYzine Hydrochloride resources
- Hydroxyzine
- Hydroxyzine (Wolters Kluwer)
- Hydroxyzine Capsules (Wolters Kluwer)
- Hydroxyzine Suspension (Wolters Kluwer)
- Hydroxyzine Syrup (Wolters Kluwer)
- Rezine (Cerner Multum)
- hydroxyzine (Cerner Multum)
- Hydroxyzine Hydrochloride (AHFS DI)
- Hydroxyzine Pamoate (AHFS DI)
- Hydroxyzine (FDA)
- Hydroxyzine Capsules (FDA)
- Hydroxyzine Injection (FDA)
- Hydroxyzine Oral Solution (FDA)
- Hydroxyzine Pamoate (FDA)
- Hydroxyzine Syrup (FDA)
- Hydroxyzine Tablets (FDA)
- Hydroxyzine (Wolters Kluwer)


